Authors:
TOURANI JM
PFISTER C
BERDAH JF
BENHAMMOUDA A
SALZE P
MONNIER A
PAULE B
GUILLET P
CHRETIEN Y
BREWER Y
DIPALMA M
UNTEREINER M
MALAURIE E
TADRIST Z
PAVLOVITCH JM
HAUTEVILLE D
MEJEAN A
AZAGURY M
MAYEUR D
LUCAS V
KRAKOWSKI I
LARREGAINFOURNIER D
ABOURACHID H
ANDRIEU JM
CHASTANG C
Citation: Jm. Tourani et al., OUTPATIENT TREATMENT WITH SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA ADMINISTRATION IN COMBINATION WITH FLUOROURACIL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A SEQUENTIAL NONRANDOMIZED-PHASE-II STUDY, Journal of clinical oncology, 16(7), 1998, pp. 2505-2513
Authors:
TOURANI JM
BENHAMMOUDA A
GUILLET P
PFISTER C
PAULE B
BERBAH JF
CHRETIEN Y
SALZE P
MONNIER A
BREWER Y
Citation: Jm. Tourani et al., SUBCUTANEOUS (SC) INTERLEUKIN-2 (IL-2) PLUS ALPHA-INTERFERON (IFN-ALPHA) AND 5-FLUOROURACIL (5FU) IN OUT-PATIENTS (PTS) WITH METASTATIC RENAL-CELL CARCINOMA (MRCC) - SCAPP-II TRIAL, European journal of cancer, 33, 1997, pp. 150-150
Authors:
TOURANI JM
JAILLONABRAHAM C
LUCAS V
CHRETIEN Y
MAYEUR D
DIPALMA M
BOAZIZ C
GRISE P
VARETTE C
PAVLOVITCH JM
LARREGAIN D
ECSTEIN E
UNTEREINER M
ANDRIEU JM
Citation: Jm. Tourani et al., SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN TREATMENT OF PATIENTSWITH METASTATIC RENAL-CELL CARCINOMA - 3-YEAR RESULTS OF SCAPP-I TRIAL, Bulletin du cancer, 84(4), 1997, pp. 351-356
Authors:
TOURANI JM
GRISE P
LUCAS V
MAYEUR D
DUFOUR B
DIPALMA M
BOAZIZ C
PAVLOVITCH JM
PUJADELAURAINE E
LARREGAIN D
UNTEREINER M
Citation: Jm. Tourani et al., INTERLEUKIN-2 IN OUTPATIENTS WITH RENAL-CELL CARCINOMA - SCAPP1 TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 297-300
Authors:
TOURANI JM
LUCAS V
MAYEUR D
DUFOUR B
DIPALMA M
BOAZIZ C
GRISE P
VARETTE C
PAVLOVITCH JM
PUJADELAURAINE E
LARREGAIN D
ECSTEIN E
UNTEREINER M
VUILLEMIN E
MERRAN S
ANDRIEU JM
Citation: Jm. Tourani et al., SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 (RIL-2) IN OUT-PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A MULTICENTER SCAPP1 TRIAL, Annals of oncology, 7(5), 1996, pp. 525-528
Authors:
DESABLENS B
FRANCOIS S
COLOMBAT P
BERTHOU C
GANDHOUR C
TOURANI JM
LAMY T
DELWAIL V
HAROUSSEAU JL
LAMOUR C
LEMEVEL A
Citation: B. Desablens et al., REPORT ON 190 LOCALIZED EXTRA-NODAL AGGRESSIVE NHL TREATED BY THE 2 GEOLAMS 02-AND-03 TRIALS, Blood, 88(10), 1996, pp. 2255-2255
Authors:
LEVY R
COLONNA P
TOURANI JM
GASTAUT JA
BRICE P
RAPHAEL M
TAILLAN B
ANDRIEU JM
Citation: R. Levy et al., HUMAN-IMMUNODEFICIENCY-VIRUS ASSOCIATED HODGKINS-DISEASE - REPORT OF 45 CASES FROM THE FRENCH REGISTRY OF HIV-ASSOCIATED TUMORS, Leukemia & lymphoma, 16(5-6), 1995, pp. 451-456
Authors:
COLOMBAT P
BLEDJORD K
CORNILLET P
DECONNINCK E
PELLERIN MP
GARDEMBAS M
GARRIGUE MA
TOURANI JM
FERRAND C
SENSEBE L
FEREC C
MILPIED N
Citation: P. Colombat et al., VALUE OF BCL2 EVALUATION WITH PCR REACTION IN PATIENTS WITH FOLLICULAR LYMPHOMAS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND PURGED AUTOLOGOUS BONE SUPPORT AS FIRST-LINE THERAPY, Blood, 86(10), 1995, pp. 3228-3228
Authors:
DERAUCOURT E
DUMONT MD
TOURANI JM
HUBSCH JP
RIQUET M
FISCHER AM
Citation: E. Deraucourt et al., ACQUIRED FACTOR-VII DEFICIENCY ASSOCIATED WITH PLEURAL LIPOSARCOMA, Blood coagulation & fibrinolysis, 5(5), 1994, pp. 833-836
Authors:
RIXE O
BENHAMMOUDA A
ANTOINE E
PETIT T
TOURANI JM
BOREL C
FRANKS C
KALIF B
MOUSSEAU M
THOMAS A
BENSFIA S
NIZRI D
SOUBRANE C
HERRERA A
BIZZARI JP
AUCLERC G
WEIL M
BANZET P
KHAYAT D
Citation: O. Rixe et al., CHEMOIMMUNOTHERAPY OF METASTATIC MELANOMA - CISPLATIN, INTERLEUKIN-2 AND IFN-ALPHA IN 91 PATIENTS, Pathologie et biologie, 42(10), 1994, pp. 1080-1081
Authors:
TOURANI JM
LEVY R
COSCAS Y
EVEN P
ANDRIEU JM
Citation: Jm. Tourani et al., LIMITED SMALL-CELL LUNG-CARCINOMA - HIGH COMPLETE RESPONSE RATE AND SURVIVAL WITH SHORT INTENSIVE CHEMOTHERAPY AND EXTENSIVE IRRADIATION - RESULTS OF A PILOT-STUDY, International journal of oncology, 3(2), 1993, pp. 347-353
Authors:
KHAYAT D
ANTOINE E
RIXE O
TOURANI JM
VUILLEMIN E
BOREL C
BENHAMMOUDA A
THILL L
FRANKS C
AUCLERC G
WEIL M
SOUBRANE C
BANZET P
Citation: D. Khayat et al., CHEMOIMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA THE SALPETRIERE HOSPITAL (SOMPS) EXPERIENCE, European journal of cancer, 29A, 1993, pp. 2-5
Authors:
KHAYAT D
BOREL C
TOURANI JM
BENHAMMOUDA A
ANTOINE E
RIXE O
VUILLEMIN E
BAZEX PA
THILL L
FRANKS R
AUCLERC G
SOUBRANE C
BANZET P
WEIL M
Citation: D. Khayat et al., SEQUENTIAL CHEMOIMMUNOTHERAPY WITH CISPLATIN, INTERLEUKIN-2, AND INTERFERON ALFA-2A FOR METASTATIC MELANOMA, Journal of clinical oncology, 11(11), 1993, pp. 2173-2180
Authors:
LU W
SHIH JWK
TOURANI JM
EME D
ALTER HJ
ANDRIEU JM
Citation: W. Lu et al., LACK OF ISOLATE-SPECIFIC NEUTRALIZING ACTIVITY IS CORRELATED WITH AN INCREASED VIRAL BURDEN IN RAPIDLY PROGRESSING HIV-1-INFECTED PATIENTS, AIDS, 7, 1993, pp. 190000091-190000099
Authors:
LU W
GRASSI F
TOURANI JM
EME D
ISRAELBIET D
ANDRIEU JM
Citation: W. Lu et al., HIGH-CONCENTRATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS HARBORING INFECTIOUS VIRUS CORRELATES WITH RAPID PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-RELATED DISEASES, The Journal of infectious diseases, 168(5), 1993, pp. 1165-1168
Authors:
TURLURE P
LEPRISE PY
LETORTOREC S
LINASSIER C
IFRAH N
DESABLENS B
TOURANI JM
LEJEUNE F
SENSEBE L
BRIERE JB
Citation: P. Turlure et al., ESSENTIAL THROMBOCYTHEMIA (ET) CLINICAL COURSE AND RESULTS OF A MULTICENTER PROSPECTIVE-STUDY, Blood, 82(10), 1993, pp. 10000197-10000197